Loading clinical trials...
Loading clinical trials...
Facteurs De Risques De Récidive D'épistaxis Chez L'adulte
We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied. The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test.
We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied : oral anticoagulants, sex, INR, anti-platelets drugs, diabetes, obesity, arterial hypertension, heart failure, hemoglobin at the admission, history of chronic rhinosinusitis, appointment with an ENT during the acute bleeding, sleep apnea, age, anatomic abnormality, recent surgery within 2 months, previous admission within 30 days in the emergency department, nasal trauma. The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test. This study aim to provide a pronostic score of recurrence that can happen after the 3 fisrt weeks after the event. When a recurrence happens before 3 weeks, this was considered to be a non control of the bleeding episode. This score will be then tested on our cohort to evaluate specificity and sensibility.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU Grenoble Alpes
La Tronche, ISERE, France
Start Date
November 2, 2024
Primary Completion Date
March 1, 2025
Completion Date
April 1, 2025
Last Updated
October 24, 2024
145
ESTIMATED participants
Lead Sponsor
University Hospital, Grenoble
NCT06997796
NCT02517294
NCT05663099
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions